|
Take Manufacturing off your Critical Path
Avecia OligoMedicines has controlled manufacturing space of 10,000 square feet dedicated to the manufacture of oligonucleotides. This contains four manufacturing suites (three multi-product and one dedicated) which comprise nine controlled environment clean rooms. We have ample space for expansion as required. Our Milford site is FDA inspected and all our cGMP manufacturing is carried out following ICHQ7a guidelines for the cGMP manufacture of bulk Active Pharmaceutical Intermediates.
Our current range of equipment comprises:
Synthesis
- 3 x 300-600mmol OligoProcess™
- 1 x 100-300mmol OligoProcess™
- 1 x 3-30mmol OligoPilot™ 400
- 5 x 1-3mmol Akta OligoPilot™
Purification
- 4 x 100-300mmol BioProcess™
- small scale up to 100mmol
Ultra-filtration
- 4 flexible scale TFF systems
- 2 x 1200mmol CUF TFF system
- 1 small scale TFF system
Freeze drying
- 1 x 6.8 sq meters shelf capacity
- 1 x 5.58 sq meters shelf capacity
- multiple small scale driers
|
